1437 related articles for article (PubMed ID: 10912914)
1. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
2. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
4. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
7. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
9. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
van Helmond Z; Miners JS; Kehoe PG; Love S
Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
[TBL] [Abstract][Full Text] [Related]
11. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report].
Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T
Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981
[TBL] [Abstract][Full Text] [Related]
12. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
13. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
[TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA; Stewart J; Ironside JW; Mann DM; Love S; Graham DI; Dewar D
J Neuropathol Exp Neurol; 1999 Jul; 58(7):711-8. PubMed ID: 10411341
[TBL] [Abstract][Full Text] [Related]
15. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
17. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.
Thal DR; Papassotiropoulos A; Saido TC; Griffin WS; Mrak RE; Kölsch H; Del Tredici K; Attems J; Ghebremedhin E
Acta Neuropathol; 2010 Aug; 120(2):169-83. PubMed ID: 20535486
[TBL] [Abstract][Full Text] [Related]
18. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
19. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
[TBL] [Abstract][Full Text] [Related]
20. APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
Peuralinna T; Tanskanen M; Mäkelä M; Polvikoski T; Paetau A; Kalimo H; Sulkava R; Hardy J; Lai SL; Arepalli S; Hernandez D; Traynor BJ; Singleton A; Tienari PJ; Myllykangas L
J Alzheimers Dis; 2011; 26(2):377-85. PubMed ID: 21654062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
